# Famotidine and Antacids for Treatment of Dyspepsia

> **NCT06241183** · PHASE4 · RECRUITING · sponsor: **Stony Brook University** · enrollment: 80 (estimated)

## Conditions studied

- Dyspepsia
- GERD
- Acid Reflux

## Interventions

- **DRUG:** Intravenous Famotidine
- **DRUG:** Oral Maalox/ Mylanta

## Key facts

- **NCT ID:** NCT06241183
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-09
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06241183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06241183, "Famotidine and Antacids for Treatment of Dyspepsia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06241183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*